Cipla Health Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions, including Asia, Africa, and Europe. Founded in 1935, Cipla has established itself as a leader in the development and manufacturing of a diverse range of healthcare products, including prescription medications, over-the-counter drugs, and wellness solutions. The company is renowned for its commitment to innovation, particularly in respiratory, cardiovascular, and anti-infective therapies. Cipla's unique approach to affordable healthcare has positioned it as a trusted name in the market, with notable achievements in expanding access to essential medicines globally. With a strong focus on quality and sustainability, Cipla Health Limited continues to make significant strides in improving health outcomes for patients worldwide.
How does Cipla Health Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cipla Health Limited's score of 18 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cipla Health Limited, headquartered in India, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical sector are increasingly focusing on sustainability and climate commitments. This includes efforts to reduce carbon footprints and enhance environmental responsibility. Cipla Health Limited may be engaging in similar practices, aligning with industry trends towards greater transparency and accountability in climate action. As the company progresses, it may establish specific targets and initiatives aimed at reducing its carbon emissions across various scopes, including Scope 1 (direct emissions), Scope 2 (indirect emissions from energy), and potentially Scope 3 (indirect emissions from the value chain).
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Cipla Health Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.